Brainsway Ltd - ADR

NASDAQ:BWAY  
7.35
-0.38 (-4.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)120.84M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.96 Million
Adjusted EPS-$0.06
See more estimates
10-Day MA$7.90
50-Day MA$8.12
200-Day MA$8.87
See more pivots

Brainsway Ltd - ADR Stock, NASDAQ:BWAY

Bynet Building, 19 Hartum Street, 3rd floor, Jerusalem, Jerusalem 9777518
Phone: +972.2.582.4030
Number of Employees: 100

Description

Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.